Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature

Autoimmunity Reviews

Volumn 6, Issue 3, 2007, Pages 196-202

  Ruffatti, Amelia ^a   Marson, Piero ^b   Pengo, Vittorio ^c   Favaro, Maria ^a   Tonello, Marta ^a   Bortolati, Maria ^a   Minucci, Daria ^b   De Silvestro, Giustina ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Clinical Cardiology   (Italy)

Author keywords

Antiphospholipid syndrome; Intravenous immunoglobulins; Plasma exchange; Pregnancy complications

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBIN III; BETAMETHASONE; CORTICOSTEROID; FRESH FROZEN PLASMA; HEPARIN CALCIUM; IMMUNOGLOBULIN; NADROPARIN; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANAMNESIS; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; CHOLANGITIS; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG SUBSTITUTION; ERYTHEMA; FETUS DEATH; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HELLP SYNDROME; HIGH RISK PATIENT; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; OLIGOHYDRAMNIOS; PLACENTA INSUFFICIENCY; PLASMAPHERESIS; PREGNANCY OUTCOME; PREGNANT WOMAN; REVIEW; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; THIRD TRIMESTER PREGNANCY; THROMBOCYTE COUNT; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; NADROPARIN; PLASMA EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846638644     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.11.002     Document Type: Review

References (25)

1. Lassere M., and Empson M. Treatment of antiphospholipid syndrome in pregnancy-a systematic review of randomized therapeutic trials. Thromb Res 114 (2004) 419-426
2. Tincani A., Branch W., Levy R.A., Piette J.C., Carp H., Rai R.S., et al. Treatment of pregnant patients with antiphospholipid syndrome. Lupus 12 (2003) 524-529
3. Erkan D., and Lockshin M.D. New treatments for antiphospholipid syndrome. Rheum Dis Clin North Am 32 (2006) 129-148
4. Lima F., Khamashta M.A., Buchanan N.M., Kerslake S., Hunt B.J., and Hughes G.R. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 14 (1996) 131-136
5. Stone S., Hunt B.J., Seed P.T., Parmar K., Khamashta M.A., and Poston L. Longitudinal evaluation of markers of endothelial cell dysfunction and hemostasis in treated antiphospholipid syndrome and in healthy pregnancy. Am J Obstet Gynecol 188 (2003) 454-460
6. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
7. Pengo V., Biasiolo A., Pegoraro C., Cucchini U., Noventa F., and Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 93 (2005) 1147-1152
8. Sailer T., Zoghlami C., Kurz C., Rumpold H., Quehenberger P., Panzer S., et al. Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant. Thromb Haemost 95 (2006) 796-801
9. Ruffatti A., Orsini A., Di Lenardo L., Nardelli G.B., Patrassi G.M., Truscia D., et al. A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss. Clin Exp Rheumatol 15 (1997) 499-505
10. Ruffatti A., Favaro M., Tonello M., De Silvestro G., Pengo V., Fais G., et al. Efficacy and safety of nadroparin in the treatment of pregnant women with antiphospholipid syndrome: a prospective cohort study. Lupus 14 (2005) 120-128
11. Ruffatti A., Tonello M., Del Ross T., Cavazzana A., Grava C., Noventa F., et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 96 (2006) 337-341
12. Bosch T. Therapeutic apheresis-state of the art in the year 2005. Ther Apher Dial 9 (2005) 459-468
13. Vora S.K., Asherson R.A., and Erkan D. Catastrophic antiphospholipid syndrome. J Intensive Care Med 21 (2006) 144-159
14. Ruffatti A., De Silvestro G., Ghirardello A., Calligaro A., Del Ross T., Thiene G., et al. A catastrophic antiphospholipid syndrome: the importance of high levels of warfarin anticoagulation. J Intern Med 235 (1994) 81-83
15. Frampton G., Cameron J.S., Thom M., Jones S., and Raftery M. Successful removal of anti-phospholipid antibody during pregnancy using plasma exchange and low-dose prednisolone. Lancet 2 (1987) 1023-1024
16. Bussel A., Boulechfar H., and Naim R. Synchronisation d'épurations plasmatiques et d'immunoglobulines polyvalentes intraveineuses. Étude consécutive de 11 patients. Ann Med Interne 144 (1993) 532-538
17. Linenberger M.L., and Price T.H. Use of cellular and plasma apheresis in the critically ill patient: Part 1: technical and physiological considerations. J Intensive Care Med 20 (2005) 18-27
18. Branch D.W., Silver R.M., Blackwell J.L., Reading J.C., and Scott J.R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80 (1992) 614-620
19. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
20. Redman C.W., Bonnar J., and Beilin L. Early platelet consumption in pre-eclampsia. Br Med J. 1 (1978) 467-469
21. Tek I., Arslan O., Arat M., Ozcan M., Akdag B., and Ilhan O. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange. Transfus Apher Sci 28 (2003) 3-7
22. Sapir T., Blank M., and Shoenfeld Y. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Ann N Y Acad Sci 1051 (2005) 743-778
23. Montgomery R.A., Zachary A.A., Racusen L.C., Leffell M.S., King K.E., Burdick J., et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 70 (2000) 887-895
24. Ibernon M., Gil-Vernet S., Carrera M., Seron D., Moreso F., Bestard O., et al. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc 37 (2005) 3743-3745
25. Fernandez-Jimenez M.C., Jimenez-Marco M.T., Hernandez D., Gonzalez A., Omenaca F., and de la Camara C. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients. Vox Sang 80 (2001) 117-120